244 related articles for article (PubMed ID: 27184108)
1. The protonation state of histidine 111 regulates the aggregation of the evolutionary most conserved region of the human prion protein.
Fonseca-Ornelas L; Zweckstetter M
Protein Sci; 2016 Aug; 25(8):1563-7. PubMed ID: 27184108
[TBL] [Abstract][Full Text] [Related]
2. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.
Sengupta I; Udgaonkar JB
Chem Commun (Camb); 2018 Jun; 54(49):6230-6242. PubMed ID: 29789820
[TBL] [Abstract][Full Text] [Related]
3. Amyloid formation characteristics of GNNQQNY from yeast prion protein Sup35 and its seeding with heterogeneous polypeptides.
Haratake M; Takiguchi T; Masuda N; Yoshida S; Fuchigami T; Nakayama M
Colloids Surf B Biointerfaces; 2017 Jan; 149():72-79. PubMed ID: 27736724
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β Peptide Induces Prion Protein Amyloid Formation: Evidence for Its Widespread Amyloidogenic Effect.
Honda R
Angew Chem Int Ed Engl; 2018 May; 57(21):6086-6089. PubMed ID: 29645399
[TBL] [Abstract][Full Text] [Related]
5. Interplay of buried histidine protonation and protein stability in prion misfolding.
Malevanets A; Chong PA; Hansen DF; Rizk P; Sun Y; Lin H; Muhandiram R; Chakrabartty A; Kay LE; Forman-Kay JD; Wodak SJ
Sci Rep; 2017 Apr; 7(1):882. PubMed ID: 28408762
[TBL] [Abstract][Full Text] [Related]
6. Structural Mechanism of Barriers to Interspecies Seeding Transmissibility of Full-Length Prion Protein Amyloid.
Ma T; Deng J; Ma S; Zhao W; Chang Z; Yu K; Yang J
Chembiochem; 2019 Nov; 20(21):2757-2766. PubMed ID: 31161647
[TBL] [Abstract][Full Text] [Related]
7. Amyloid Properties of Asparagine and Glutamine in Prion-like Proteins.
Zhang Y; Man VH; Roland C; Sagui C
ACS Chem Neurosci; 2016 May; 7(5):576-87. PubMed ID: 26911543
[TBL] [Abstract][Full Text] [Related]
8. Impact of N-glycosylation site variants during human PrP aggregation and fibril nucleation.
Mishra R; Elgland M; Begum A; Fyrner T; Konradsson P; Nyström S; Hammarström P
Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):909-921. PubMed ID: 30935958
[TBL] [Abstract][Full Text] [Related]
9. Protein-solvent interfaces in human Y145Stop prion protein amyloid fibrils probed by paramagnetic solid-state NMR spectroscopy.
Aucoin D; Xia Y; Theint T; Nadaud PS; Surewicz K; Surewicz WK; Jaroniec CP
J Struct Biol; 2019 Apr; 206(1):36-42. PubMed ID: 29679649
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of amyloid fibrils formed by a peptide from the yeast prion protein Sup35: AFM and Tip-Enhanced Raman Scattering studies.
Krasnoslobodtsev AV; Deckert-Gaudig T; Zhang Y; Deckert V; Lyubchenko YL
Ultramicroscopy; 2016 Jun; 165():26-33. PubMed ID: 27060278
[TBL] [Abstract][Full Text] [Related]
11. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of prion protein-derived cell-penetrating peptides is modulated by pH but independent of amyloid formation.
Mukundan V; Maksoudian C; Vogel MC; Chehade I; Katsiotis MS; Alhassan SM; Magzoub M
Arch Biochem Biophys; 2017 Jan; 613():31-42. PubMed ID: 27818203
[TBL] [Abstract][Full Text] [Related]
13. Prion-Like Proteins in Phase Separation and Their Link to Disease.
Sprunger ML; Jackrel ME
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356638
[TBL] [Abstract][Full Text] [Related]
14. Evolutionarily Conserved Proline Residues Impede the Misfolding of the Mouse Prion Protein by Destabilizing an Aggregation-competent Partially Unfolded Form.
Pal S; Udgaonkar JB
J Mol Biol; 2022 Dec; 434(23):167854. PubMed ID: 36228749
[TBL] [Abstract][Full Text] [Related]
15. Structural Studies of Amyloid Proteins at the Molecular Level.
Eisenberg DS; Sawaya MR
Annu Rev Biochem; 2017 Jun; 86():69-95. PubMed ID: 28125289
[TBL] [Abstract][Full Text] [Related]
16. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
17. Effects of Cu
Sakaguchi Y; Nakamura R; Konishi M; Hatakawa Y; Toyoda H; Akizawa T
Biochem Biophys Res Commun; 2019 Jun; 514(3):798-802. PubMed ID: 31079927
[TBL] [Abstract][Full Text] [Related]
18. The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro.
Honda RP; Kuwata K
Sci Rep; 2017 Apr; 7(1):562. PubMed ID: 28373719
[TBL] [Abstract][Full Text] [Related]
19. Perfecting prediction of mutational impact on the aggregation propensity of the ALS-associated hnRNPA2 prion-like protein.
Batlle C; Fernández MR; Iglesias V; Ventura S
FEBS Lett; 2017 Jul; 591(13):1966-1971. PubMed ID: 28542905
[TBL] [Abstract][Full Text] [Related]
20. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
Yamaguchi K; Matsumoto T; Kuwata K
Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
